GCG and macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss: Teduglutide, the first glucagon-like peptide 2 analogue, has been demonstrated to facilitate the absorption of gut nutrient and lessen the need for parenteral assistance in patients with Short Bowel Syndrome (SBS).